贝斯美(300796) - 2023 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2023 was ¥103,223,861.38, a decrease of 40.74% compared to the same period last year[5] - The net profit attributable to shareholders was ¥284,028.22, down 99.29% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥142,444.58, a decline of 99.65% compared to the previous year[5] - Total operating revenue for Q3 2023 was ¥466,347,444.96, a decrease of 14.65% compared to ¥546,480,735.01 in Q3 2022[23] - Operating profit for Q3 2023 was ¥106,705,589.48, a decline of 23.25% from ¥139,134,410.78 in Q3 2022[23] - The company reported a net profit margin of approximately 22.85% for Q3 2023, down from 25.43% in Q3 2022[23] - The net profit for Q3 2023 was CNY 81,653,860.87, a decrease of 30.7% compared to CNY 117,959,518.54 in Q3 2022[24] - The total comprehensive income for the period was CNY 81,807,818.59, compared to CNY 117,959,518.54 in the same quarter last year[24] Assets and Liabilities - Total assets at the end of Q3 2023 were ¥2,065,563,875.42, a decrease of 1.67% from the end of the previous year[5] - Current assets totaled ¥638,549,420.95 as of September 30, 2023, down 34.83% from ¥979,609,788.27 at the beginning of the year[20] - Total liabilities decreased to ¥373,876,945.25 in Q3 2023, a reduction of 20.29% from ¥469,242,056.36 in Q1 2023[21] - Total equity increased to ¥1,691,686,930.17 as of September 30, 2023, up 3.68% from ¥1,631,501,334.92 at the beginning of the year[21] - The company's total equity attributable to shareholders increased by 3.57% to ¥1,664,415,701.71 compared to the end of the previous year[5] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥203,712,410.30, an increase of 21.91%[5] - The net cash flow from operating activities was CNY 203,712,410.30, up by 21.9% compared to CNY 167,096,906.18 in Q3 2022[25] - The company reported a net cash outflow from investing activities of CNY 324,918,030.33, worsening from a net outflow of CNY 151,915,100.65 in the previous year[26] - The cash and cash equivalents at the end of the period were CNY 403,897,807.44, down from CNY 765,318,013.87 at the end of Q3 2022[26] - The company experienced a decrease in cash inflows from financing activities, with a net cash outflow of CNY 84,306,420.07 compared to a net inflow of CNY 423,935,208.29 in Q3 2022[26] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8.512 million[12] - The largest shareholder, Ningbo Baismei Investment Holding Co., Ltd., holds 23.02% of shares, totaling 83,118,980 shares[12] - The top ten shareholders include several investment firms, with the second-largest shareholder holding 4.43% of shares, totaling 16,013,243 shares[12] Production and Investment - The production of the main product, Dimethylpentylamine, decreased by 45.08% year-on-year due to temporary parking and safety inspections[16] - The annual production project of 8,500 tons of ketone series green materials has completed construction and is now in the trial production phase[17] - The company established a wholly-owned subsidiary, Shanghai Beiling Trading Co., Ltd., with a registered capital of 1 million RMB to expand its business operations[16] - Investment activities resulted in a net cash outflow of ¥324,918,030.33, an increase of 113.88% year-on-year due to increased land purchases and project investments[10] - The company plans to participate in the bidding for state-owned land use rights with a budget of up to 130 million RMB, acquiring three plots of land totaling 330,135.67 square meters for 123.81 million RMB[15] - The company has signed a land use rights transfer contract with the Anhui Provincial Natural Resources and Planning Bureau for the acquired land[15] Research and Development - Research and development expenses for Q3 2023 were ¥27,146,446.72, slightly up from ¥26,875,017.29 in Q3 2022[23] - The company’s financial report indicates a significant focus on expanding production capabilities and optimizing resource allocation[19] - The company is committed to ensuring safe and efficient production during the trial phase of new projects[17]